Active Ingredient History

  • Now
Serelaxin is a medication which is marketed in Russia for the treatment of acute heart failure (AHF), targeting the relaxin receptor. It was also under development in other places in the world, including in the United States, Europe, and Asia, but ultimately was not marketed in these areas.   Wikipedia

More Chemistry
human relaxin 2 (relaxin h2) | human relaxin recombinant | recombinant human relaxin | rlx030 | serelaxin


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue